This is the authors' abstract. We don't add key points for this paper.
Background: Daikenchuto is a traditional Japanese herbal medicine (Kampo) that has been widely used because of its low cost and minimal side effects. It is used for early patient recovery after abdominal surgery and to prevent postoperative paralytic ileus in various surgeries, including colon and rectal cancer. Many studies have reported the usefulness of perioperative administration of Daikenchuto; however, few have examined its association with healthcare economics.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: